Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI110317

Suppressive Effects of 24,25-Dihydroxycholecalciferol on Bone Resorption Induced by Acute Bilateral Nephrectomy in Rats

Jana Henriette Pavlovitch, Giulia Cournot-Witmer, Agnes Bourdeau, and Sonia Balsan

Laboratoire des Tissus Calcifiés, Centre National de la Recherche Scientifique ER 126 and Institut National de la Santé et de la Recherche Medicale U. 30, Hôpital des Enfants Malades, 75015 Paris, France

Research Laboratory for Calcium Metabolism, Department of Orthopedic Surgery and Medicine, University of Zurich, 8008 Zurich, Switzerland

Institut de Médecine, Laboratorie de Radio-Immunologie, Université de Liège, 4000 Liège, Belgium

Find articles by Pavlovitch, J. in: PubMed | Google Scholar

Laboratoire des Tissus Calcifiés, Centre National de la Recherche Scientifique ER 126 and Institut National de la Santé et de la Recherche Medicale U. 30, Hôpital des Enfants Malades, 75015 Paris, France

Research Laboratory for Calcium Metabolism, Department of Orthopedic Surgery and Medicine, University of Zurich, 8008 Zurich, Switzerland

Institut de Médecine, Laboratorie de Radio-Immunologie, Université de Liège, 4000 Liège, Belgium

Find articles by Cournot-Witmer, G. in: PubMed | Google Scholar

Laboratoire des Tissus Calcifiés, Centre National de la Recherche Scientifique ER 126 and Institut National de la Santé et de la Recherche Medicale U. 30, Hôpital des Enfants Malades, 75015 Paris, France

Research Laboratory for Calcium Metabolism, Department of Orthopedic Surgery and Medicine, University of Zurich, 8008 Zurich, Switzerland

Institut de Médecine, Laboratorie de Radio-Immunologie, Université de Liège, 4000 Liège, Belgium

Find articles by Bourdeau, A. in: PubMed | Google Scholar

Laboratoire des Tissus Calcifiés, Centre National de la Recherche Scientifique ER 126 and Institut National de la Santé et de la Recherche Medicale U. 30, Hôpital des Enfants Malades, 75015 Paris, France

Research Laboratory for Calcium Metabolism, Department of Orthopedic Surgery and Medicine, University of Zurich, 8008 Zurich, Switzerland

Institut de Médecine, Laboratorie de Radio-Immunologie, Université de Liège, 4000 Liège, Belgium

Find articles by Balsan, S. in: PubMed | Google Scholar

Published September 1, 1981 - More info

Published in Volume 68, Issue 3 on September 1, 1981
J Clin Invest. 1981;68(3):803–810. https://doi.org/10.1172/JCI110317.
© 1981 The American Society for Clinical Investigation
Published September 1, 1981 - Version history
View PDF
Abstract

The possible suppressive effects of 24,25-dihydroxycholecalciferol on secondary hyperparathyroidism and increased bone resorption were investigated in adult rats raised on a diet normal in calcium, phosphorus, and vitamin D, and subjected to acute bilateral nephrectomy. The animals had received subcutaneous radiocalcium 4 wk before the experiment. 5 h after nephrectomy an increase in serum total calcium, 45Ca-specific activity, citrate, phosphorus, and magnesium concentrations were observed. Serum immunoreactive parathyroid hormone increased, while serum calcitonin decreased. The osteoclast count in the tibial metaphyses was augmented. The biochemical and histological changes observed were partly parathyroid hormone and calcitonin independent, as they also occurred in parathyroidectomized hypocalcemic rats. Pretreatment with 650 pmol of 24,25-dihydroxycholecalciferol 16 h before nephrectomy prevented bone calcium mobilization and diminished the rise in serum total calcium and citrate both in parathyroid-intact and in parathyroidectomized animals. In parathyroid-intact rats, serum immunoreactive parathyroid hormone and calcitonin remained normal in spite of the fall in serum-ionized calcium, and the number of osteoclasts did not increase. In parathyroidectomized rats, 24,25-dihydroxycholecalciferol did not prevent the postnephrectomy rise in the osteoclast count. This latter observation suggests that this metabolite exerts its effect on bone either by acting on cells other than osteoclasts, i.e., the osteocytes, or by inhibiting cell activity. At equimolar dosage 1,25-dihydroxycholecalciferol had a potent stimulatory effect on bone resorption. This effect of 1,25-dihydroxycholecalciferol was partly blocked by the simultaneous administration of 24,25-dihydroxycholecalciferol.

The potential clinical significance of these observations remains to be determined.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 803
page 803
icon of scanned page 804
page 804
icon of scanned page 805
page 805
icon of scanned page 806
page 806
icon of scanned page 807
page 807
icon of scanned page 808
page 808
icon of scanned page 809
page 809
icon of scanned page 810
page 810
Version history
  • Version 1 (September 1, 1981): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts